Sollte ich retinoyl tripeptide-35 in der Schwangerschaft meiden? | VeriMom

What to use instead

Pregnancy-safe ingredients that serve a similar function:

FAQ

Ist retinoyl tripeptide-35 in der Schwangerschaft sicher?

Ingredient is described in patents/databases as the product of retinoic acid and tripeptide-35 (i.e. contains a retinoid moiety), which creates a structural alert for retinoid-associated reproductive risk; no harmonised CLP classification, no EU Annex II/III listing, and no peer‑reviewed reproductive/developmental studies for this specific compound were located. Evidence: ingredient descriptions/patents identify it as retinoyl (retinoic acid) conjugate. Sources searched found no SCCS/CIR opinions or PubMed toxicology studies.

Ist retinoyl tripeptide-35 während des Stillens sicher?

Same rationale as pregnancy: presence of a retinoid moiety raises class-based concern. No data were found on milk transfer or lactation-specific studies for this compound. No regulatory restriction (Annex II/III) or harmonised H‑codes for this specific ingredient were found.

Ist retinoyl tripeptide-35 sicher für Babyhaut?

No infant-specific studies located. Because adult topical absorption is plausible (retinoid moiety, low molecular-weight peptide conjugates sometimes penetrate), exposure for infants (0–3 yr) is increased by +1 per your rules. No evidence was found that the ingredient is non‑absorbable or that it does not release retinoic acid in vivo.

Wie bewertet VeriMom retinoyl tripeptide-35?

VeriMom bewertet retinoyl tripeptide-35 mit 13/100 (hohes Risiko) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.

Was sind schwangerschaftssichere Alternativen zu retinoyl tripeptide-35?

Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu retinoyl tripeptide-35 basierend auf ähnlicher Funktion.